Shingles vaccine linked to lower dementia risk
Older adults vaccinated against shingles appear significantly less likely to develop dementia. That’s striking, because the vaccine targets a skin condition, not a brain disease.
Shingles is caused by the varicella-zoster virus, the same virus responsible for chickenpox. After the initial infection, the virus lies dormant in nerve cells. As immunity weakens with age, it can reactivate. Researchers have long suspected that this reactivation can cause damage in the brain.
A new study now shows that Shingrix, the only shingles vaccine available in the United States, offers measurable protection. The researchers followed elderly nursing home residents and found that those who received at least one dose were 24 percent less likely to receive a dementia diagnosis over a four-year period, compared to unvaccinated residents. The findings were published in the peer-reviewed journal Annals of Internal Medicine.
Virus and brain inflammation
One possible explanation involves low-grade inflammation. The varicella-zoster virus may trigger chronic inflammation in the nervous system (neuroinflammation), which has long been associated with dementia development. By suppressing viral reactivation, the vaccine could also dampen that inflammatory pathway.
This is an observational study among nursing home residents, a vulnerable group whose results may not generalize to all older adults. An association is not the same as proof of causation. The researchers themselves describe this as a significant but preliminary finding that warrants further investigation.
An existing vaccine, a new insight
What makes this study especially relevant from a longevity perspective is that no new therapy is required. Shingrix is already widely available. If the protective effect holds up in larger, more diverse populations, shingles vaccination could carry considerably more weight in prevention strategies for older adults.
The study fits a broader pattern: infectious agents and immune activity likely play a larger role in neurodegenerative disease than previously assumed.